|
HTT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.753200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.154900E-04 |
| Normal-vs-Stage2 |
1.835390E-01 |
| Normal-vs-Stage3 |
8.414700E-04 |
| Normal-vs-Stage4 |
4.34009999999985E-05 |
| Stage1-vs-Stage2 |
4.580400E-01 |
| Stage1-vs-Stage3 |
2.494200E-01 |
| Stage1-vs-Stage4 |
4.501900E-02 |
| Stage2-vs-Stage3 |
1.639210E-01 |
| Stage2-vs-Stage4 |
3.602000E-02 |
| Stage3-vs-Stage4 |
2.447000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.637700E-04 |
| Normal-vs-AfricanAmerican |
4.678000E-03 |
| Normal-vs-Asian |
3.983400E-04 |
| Caucasian-vs-AfricanAmerican |
7.560400E-01 |
| Caucasian-vs-Asian |
1.118230E-01 |
| AfricanAmerican-vs-Asian |
2.320200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.437400E-04 |
| Normal-vs-Female |
1.378560E-01 |
| Male-vs-Female |
7.011800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.520090E-02 |
| Normal-vs-Extreme_Weight |
1.79590000004559E-06 |
| Normal-vs-Obese |
1.188500E-02 |
| Normal-vs-Extreme_Obese |
1.256020E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.136200E-01 |
| Normal_Weight-vs-Obese |
7.550000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.908000E-01 |
| Extreme_Weight-vs-Obese |
4.928300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.410830E-01 |
| Obese-vs-Extreme_Obese |
7.627000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.323970E-02 |
| Normal-vs-Age(41-60Yrs) |
1.904780E-03 |
| Normal-vs-Age(61-80Yrs) |
7.046900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.519630E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.061400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.914000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.661000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.781400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.450800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.264000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.88149999999743E-05 |
| Normal-VS-Type2 PRCC |
1.087550E-02 |
| Normal-VS-KIRP CIMP |
5.421600E-03 |
| Normal-VS-Unclassified PRCC |
9.246800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.838200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.825400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.631890E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.615400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.270100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.960000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3543999999931E-05 |
| Normal-vs-N1 |
5.55810000000267E-05 |
| Normal-vs-N2 |
2.069800E-01 |
| N0-vs-N1 |
7.323000E-01 |
| N0-vs-N2 |
5.081000E-01 |
| N1-vs-N2 |
4.073600E-01 |
|
|
